Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
THWART-1: A-101 in common warts
NCT03687372Phase 3Completed
- Sponsor
- Aclaris Therapeutics, Inc.
- Start
- Sep 2018
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of hydrogen peroxide gel in common wart, sponsored by Aclaris Therapeutics, Inc.. Started Sep 2018; status: completed.
02
Drugs
hydrogen peroxide gel
03
Conditions
common wart
Beyond the preview
Go deeper on NCT03687372.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03687372.